Medium Risk

Bharat Rasayan Limited

Chemical and Chemical Products, Pharmaceuticals, Medicinal Chemicals and Botanical Products

CIN: L24119DL1989PLC036264 FY: - Revenue: ₹1,173.0 Cr
5.7
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
3.9
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
3.0

Financial Exposure

Est. Compliance Cost₹2–7 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated38,422.4 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyYes
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.7
Impact Materiality5.1
QuadrantDual Materiality

Supply Chain

MSME Sourcing—%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

AI Risk Summary

**Financial Risk Summary – Bharat Rasayan Limited** Bharat Rasayan faces critical compliance exposure as its 10.0/10 compliance risk rating indicates material gaps in SEBI BRSR Core reporting obligations, with potential enforcement action and delisting risk for top-tier listed companies. Extended Producer Responsibility (EPR) liability represents the largest unquantified financial exposure (6.5/10 risk), compounded by unknown EPR applicability status across its chemical and pharmaceutical product portfolio—failure to establish producer responsibility systems could trigger statutory penalties and operational disruptions. The estimated compliance remediation cost of ₹2–7 crore, though currently absorbed within operating margins (0.6–0.6% of ₹1173 crore revenue), understates true exposure if the company faces retrospective EPR liability or Scope 1/2 emissions disclosure gaps given absent baseline emissions data. Immediate priority: clarify EPR applicability across product categories and establish BRSR P6 disclosure infrastructure to mitigate regulatory penalties under SEBI enforcement regime.

Source: Bharat Rasayan Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →